Dynamic Medicine Prices for Health-Economic Analyses in the Netherlands: A Case for Integrating Pre- and Post-Exclusivity Price Dynamics
Journal of Market Access & Health Policy · 2026-10-29 · 14 (4) · 65
DOI: 10.3390/jmahp14040065 ↗Abstract
Introduction: Medicine prices change over the product life cycle, especially around loss of exclusivity (LoE), yet economic evaluations often assume constant prices, which may bias cost-effectiveness and budget impact estimates. Methods: We developed and internally validated a forecasting approach for Dutch medicine price trajectories for use in cost-effectiveness analyses. Using monthly Farminform sales data (from 2000 onwards) for 384 Anatomical Therapeutic Chemical (ATC) codes meeting the inclusion criteria (>5 years of data,
EUVIMED